Matthew is an associate editor for The American Journal of Managed Care® (AJMC®). He joined AJMC® in 2019 and creates content for Medical World News®, a 24-hour online program developed MJH Life Sciences® focusing on pressing topics within managed care, as well as the nonwork-related activities of health care stakeholders.
He has a BA in journalism & media studies and economics from Rutgers University. You can connect with Matthew on LinkedIn.
Guselkumab Associated With Improved HRQOL, Skin Manifestations in Patients With Psoriasis
September 18th 2021Treatment of guselkumab was found to be safe and effective in improving health-related quality-of-life (HRQOL) and skin manifestations of patients with moderate to severe psoriasis in a real-world setting.
High OOP Costs for Treatment of Psoriatic Disease Found in Medicare Beneficiaries
September 15th 2021Medicare beneficiaries with psoriasis and psoriatic arthritis were found to pay high annual out-of-pocket (OOP) costs for treatment, which researchers attributed to rising drug prices and reliance on co-insurance for patient cost-sharing.
Comorbid Ophthalmic, Systemic Conditions Linked With Higher Risk of Dementia
September 15th 2021People with both ophthalmic and systemic conditions were found to be at higher risk of dementia compared with those with only 1 such condition. Some ophthalmic conditions—age-related macular degeneration, cataract, and diabetes-related eye disease—also increased risk on their own.
Spotlighting Social, Emotional Needs in Underserved Populations With Cancer
September 14th 2021Psychological and emotional needs specific to populations with cancer are often overlooked in clinical research, including those of adolescents, young adults, immigrants, and people of lower socioeconomic status.
Alpha-Glucosidase Inhibitor Use in Type 2 Diabetes Linked With Increased Psoriatic Disease Risk
September 11th 2021Discontinued use and high dosage of alpha-glucosidase inhibitors in combination with metformin was shown to increase risk of psoriasis and psoriatic arthritis in patients with type 2 diabetes compared with those given only metformin.
School-Based Vision Program Shown to Improve Short-term Academic Performance in Adolescents
September 10th 2021Students in grades 3 to 7 who were given eyeglasses as part of a school-based vision program were found to achieve better reading scores and exhibit improved academic achievement over 1 year.
Phase 2 Study Finds Tildrakizumab Effective for PsA Manifestations
September 9th 2021Findings of a phase 2b study indicated that use of tildrakizumab was associated with significant improvements in joint and skin manifestations of patients with psoriatic arthritis (PsA), although improvement in symptoms of dactylitis and enthesitis were not observed.
Unraveling the Physical, Mental Health Impacts of 9/11, 2 Decades Later: Part 1
September 9th 2021In part 1 of a 2-part series, we look at the current physical and mental health risks first responders and survivors of the 9/11 attacks continue to face, as well as unmet needs that may warrant future intervention.
Herbal Tea Consumption May Reduce Nonmotor Symptom Burden in Parkinson Disease
August 30th 2021Patients with idiopathic Parkinson disease given Origanum majorana tea in combination with conventional medication exhibited significant improvements in depressive and nonmotor symptom burden vs placebo, although improvement of motor symptoms was not significant.
Study Finds Significant Glaucoma Surgery, Mortality Risk Link in Elderly Patients
August 25th 2021Elderly patients who underwent surgery for glaucoma had a greater risk of all-cause and cause-specific mortality than those who did not have surgery, including greater risk of cancer and neurologic cause–related mortality.
Study Finds Home-Based Postoperative Management of Deep Brain Stimulation Safe, Effective
August 23rd 2021Postoperative management of deep brain stimulation in patients with Parkinson disease was shown to be safe and effective when administered at home, which may reduce necessity of in-clinic visits and care access issues.
Aflibercept Likely to Improve Severity, Complications of Nonproliferative Diabetic Retinopathy
August 21st 2021Findings of the PANORAMA randomized clinical trial show that when patients with severe nonproliferative diabetic retinopathy were treated with intravitreal aflibercept, severity improved over 100 weeks and the likelihood of vision-threatening complications significantly reduced.
Low Safety Risk Observed in Office-Based, Operating Room Anti-VEGF Intravitreal Injections
August 19th 2021A low risk of adverse safety outcomes was observed in anti–vascular endothelial growth factor (VEGF) intravitreal injections performed in office-based and operating room settings, with a higher rate of culture-positive endophthalmitis found in the office setting.
AHA Releases Scientific Statement on OSA, Cardiovascular Disease Link in Children and Adolescents
August 18th 2021The scientific statement addresses current knowledge regarding the impact of obstructive sleep apnea on the cardiovascular health of children and adolescents, as well as best practices to evaluate symptoms.